FDA's Expanded Access and Compassionate Use Rules' Impact on Mesothelioma Treatment
MesoTV Podcast: Conversations Impacting the Mesothelioma Community - Un pódcast de Mesothelioma Applied Research Foundation
Adnan Jaigirdar, MD, FACS, provided an overview of the U.S. Food and Drug Administration (FDA) expanded access program (compassionate use) for investigative therapies for mesothelioma patients.
